- Home
- AXDX vs XAIR Comparison
AXDX vs XAIR Comparison
Compare AXDX & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXDX
- XAIR
- Stock Information
- Founded
- AXDX 1982
- XAIR 2011
- Country
- AXDX United States
- XAIR United States
- Employees
- AXDX N/A
- XAIR N/A
- Industry
- AXDX Biotechnology: Laboratory Analytical Instruments
- XAIR Medical/Dental Instruments
- Sector
- AXDX Industrials
- XAIR Health Care
- Exchange
- AXDX Nasdaq
- XAIR Nasdaq
- Market Cap
- AXDX 27.5M
- XAIR 26.0M
- IPO Year
- AXDX 1996
- XAIR N/A
- Fundamental
- Price
- AXDX $1.07
- XAIR $0.42
- Analyst Decision
- AXDX Hold
- XAIR Strong Buy
- Analyst Count
- AXDX 1
- XAIR 4
- Target Price
- AXDX $1.00
- XAIR $3.67
- AVG Volume (30 Days)
- AXDX 74.2K
- XAIR 2.3M
- Earning Date
- AXDX 11-07-2024
- XAIR 02-10-2025
- Dividend Yield
- AXDX N/A
- XAIR N/A
- EPS Growth
- AXDX N/A
- XAIR N/A
- EPS
- AXDX N/A
- XAIR N/A
- Revenue
- AXDX $11,909,000.00
- XAIR $2,342,000.00
- Revenue This Year
- AXDX $0.66
- XAIR $230.80
- Revenue Next Year
- AXDX $3.44
- XAIR $265.55
- P/E Ratio
- AXDX N/A
- XAIR N/A
- Revenue Growth
- AXDX N/A
- XAIR 685.91
- 52 Week Low
- AXDX $0.73
- XAIR $0.30
- 52 Week High
- AXDX $2.09
- XAIR $2.17
- Technical
- Relative Strength Index (RSI)
- AXDX 37.88
- XAIR 51.29
- Support Level
- AXDX $1.07
- XAIR $0.34
- Resistance Level
- AXDX $1.17
- XAIR $0.38
- Average True Range (ATR)
- AXDX 0.11
- XAIR 0.06
- MACD
- AXDX 0.01
- XAIR 0.00
- Stochastic Oscillator
- AXDX 20.51
- XAIR 40.62
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.